Objectives The influence of N7-methylguanosine (m7G) on cancer prognosis and immune
response has been well-reported. However, the role of m7G-related long non-coding RNAs …

Bladder cancer (BC) is a representative malignant tumor type, and the significance of N7-
methyguanosine (m7G)-related lncRNAs in BC is still unclear. Utilizing m7G-related …

Abnormal m6A methylation plays a significant role in cancer progression. Increasingly,
researchers have focused on developing lncRNA signatures to evaluate the prognosis of …

Background Bladder urothelial carcinoma (BLCA) is the second prevalent genitourinary
carcinoma globally. N7-methylguanosine (m7G) is important for tumorigenesis and …

Background As a novel type of the prevalent post-transcriptional modifications, N7-
methylguanosine (m7G) modification is essential in the tumorigenesis, progression, and …

Abstract Background N6-methyladenosine (m6A) related long noncoding RNAs (lncRNAs)
may have prognostic value in bladder cancer for their key role in tumorigenesis and innate …

Both lncRNAs and the N6-methyladenosine (m6A) modification are key regulators of
tumorigenesis and innate immunity. However, little is known about the m6A modification of …

Background Bladder cancer (BC) is a commonly occurring malignant tumor of the urinary
system, demonstrating high global morbidity and mortality rates. BC currently lacks widely …

Background: N6-methyladenosine (m6A) is the most common form of mRNA-and long
noncoding RNA (lncRNA)-specific internal modification encountered in eukaryotes, with …

The role of 5‐methylcytosine‐related long noncoding RNAs (m5C‐lncRNAs) in bladder
cancer (BLCA) remains unclear. Here, we aim to study the prognostic value, gene …